Loncar Cancer Immunotherapy ETF – NASDAQ:CNCR
Loncar Cancer Immunotherapy ETF stock price today
$9.1
-3.39
-27.14%
Market closed
Open in about 9 hours
Loncar Cancer Immunotherapy ETF stock price monthly change
-17.01%
month
Loncar Cancer Immunotherapy ETF stock price quarterly change
-17.01%
quarter
Loncar Cancer Immunotherapy ETF stock price yearly change
-8.23%
year
Loncar Cancer Immunotherapy ETF key metrics
Market Cap | 12.00M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLoncar Cancer Immunotherapy ETF stock price history
Loncar Cancer Immunotherapy ETF stock forecast
Loncar Cancer Immunotherapy ETF financial statements
Loncar Cancer Immunotherapy ETF other data
Horiba: Wonderful Japanese Company At A Very Attractive Price
Week In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4B
Week In Review: Novartis In $1 Billion Deal For DTx Pharma
CytoDyn: It Only Takes One Hit
Coherus: 2022 Is In Many Ways A Make Or Break Year
Can Intellia One-Up Alnylam In Transthyretin Amyloidosis?
Selecta: ImmTOR Could Change Autoimmune Disorder Treatment Landscape
SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play
Adicet Bio: A First Take
-
What's the price of Loncar Cancer Immunotherapy ETF stock today?
One share of Loncar Cancer Immunotherapy ETF stock can currently be purchased for approximately $9.1.
-
When is Loncar Cancer Immunotherapy ETF's next earnings date?
Unfortunately, Loncar Cancer Immunotherapy ETF's (CNCR) next earnings date is currently unknown.
-
Does Loncar Cancer Immunotherapy ETF pay dividends?
Yes, Loncar Cancer Immunotherapy ETF pays dividends and its trailing 12-month yield is 1.12% with 0% payout ratio. The last Loncar Cancer Immunotherapy ETF stock dividend of $0.29 was paid on 4 Jan 2021.
-
How much money does Loncar Cancer Immunotherapy ETF make?
Loncar Cancer Immunotherapy ETF has a market capitalization of 12.00M.
-
What is Loncar Cancer Immunotherapy ETF's stock symbol?
Loncar Cancer Immunotherapy ETF is traded on the NASDAQ under the ticker symbol "CNCR".
-
What is Loncar Cancer Immunotherapy ETF's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of Loncar Cancer Immunotherapy ETF?
Shares of Loncar Cancer Immunotherapy ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Loncar Cancer Immunotherapy ETF went public?
Loncar Cancer Immunotherapy ETF is publicly traded company for more then 9 years since IPO on 14 Oct 2015.
Loncar Cancer Immunotherapy ETF company profile:
Exchange:
NASDAQ
Full time employees:
0
Industry:
Asset Management
Sector:
Financial Services
The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. At least 80% of its total assets will be invested in the component securities of the index. The fund is non-diversified.
,
CIK: 0001540305
ISIN: US26922A8264
CUSIP: 26922A826
